Literature DB >> 7545561

Nitric oxide: role in neurotoxicity.

V L Dawson1.   

Abstract

1. Nitric oxide (NO) is a novel neuronal messenger molecule which interacts with surrounding neurones, not by synaptic transmission but by diffusion between cells. 2. NO is produced following stimulation of the enzyme, NO synthase (NOS). After synthesis, NO exerts its biological actions by diffusion to the site of action. Therefore, the way to regulate the physiological actions of NO is to regulate NOS. 3. NOS is activated by the influx of calcium from glutamate-activated N-methyl-D-aspartate receptors. Overactivation of these receptors leads to overproduction of NO and neuronal cell death. 4. NOS can be regulated at the catalytic site, at the flavo-proteins, at the calmodulin site and by phosphorylation. 5. In excess, NO is toxic to neurones. This toxicity is mediated largely by an interaction with the superoxide anion, presumably through the generation of the oxidant, peroxynitrite. 6. NO or peroxynitrite-mediated neuronal injury involves the activation of the nuclear protein, poly(ADP-ribose)synthetase.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7545561     DOI: 10.1111/j.1440-1681.1995.tb02005.x

Source DB:  PubMed          Journal:  Clin Exp Pharmacol Physiol        ISSN: 0305-1870            Impact factor:   2.557


  18 in total

1.  S-nitrosylation of fatty acid synthase regulates its activity through dimerization.

Authors:  Min Sik Choi; Ji-Yong Jung; Hyoung-June Kim; Mi Ra Ham; Tae Ryong Lee; Dong Wook Shin
Journal:  J Lipid Res       Date:  2016-02-05       Impact factor: 5.922

2.  Activation of neuronal NMDA receptors induces superoxide-mediated oxidative stress in neighboring neurons and astrocytes.

Authors:  Reno C Reyes; Angela M Brennan; Yiguo Shen; Ylva Baldwin; Raymond A Swanson
Journal:  J Neurosci       Date:  2012-09-12       Impact factor: 6.167

3.  Oxidants and antioxidants in hypoxic ischaemic encephalopathy.

Authors:  V N Thorat; A N Suryakar; A S Sardeshmukh; S S Sarawade
Journal:  Indian J Clin Biochem       Date:  2004-07

4.  Peroxynitrite decomposition catalysts: therapeutics for peroxynitrite-mediated pathology.

Authors:  D Salvemini; Z Q Wang; M K Stern; M G Currie; T P Misko
Journal:  Proc Natl Acad Sci U S A       Date:  1998-03-03       Impact factor: 11.205

5.  Stabilization of growing retinal axons by the combined signaling of nitric oxide and brain-derived neurotrophic factor.

Authors:  A F Ernst; G Gallo; P C Letourneau; S C McLoon
Journal:  J Neurosci       Date:  2000-02-15       Impact factor: 6.167

6.  Interaction of nitric oxide donors and ascorbic acid on D-[3H] aspartate efflux from rat striatal slices.

Authors:  M Reiser; L Schild; G Keilhoff; G Wolf
Journal:  Neurochem Res       Date:  1999-01       Impact factor: 3.996

7.  Regulation of M1 muscarinic receptor-mediated signaling in intact cells by exogenous, but not endogenously produced, nitric oxide.

Authors:  A M Parsons; J L Sorman; E E El-Fakahany
Journal:  Neurochem Res       Date:  1999-01       Impact factor: 3.996

8.  Neurodegeneration and glia response in rat hippocampus following nitro-L-arginine methyl ester (L-NAME).

Authors:  G J Harry; R Sills; M J Schlosser; W E Maier
Journal:  Neurotox Res       Date:  2001-07       Impact factor: 3.911

9.  NMDA receptor-mediated refinement of a transient retinotectal projection during development requires nitric oxide.

Authors:  A F Ernst; H H Wu; E E El-Fakahany; S C McLoon
Journal:  J Neurosci       Date:  1999-01-01       Impact factor: 6.167

10.  Zinc inhibits astrocyte glutamate uptake by activation of poly(ADP-ribose) polymerase-1.

Authors:  Sang Won Suh; Koji Aoyama; Conrad C Alano; Christopher M Anderson; Aaron M Hamby; Raymond A Swanson
Journal:  Mol Med       Date:  2007 Jul-Aug       Impact factor: 6.354

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.